|Day Low/High||48.84 / 50.62|
|52 Wk Low/High||48.61 / 85.83|
Eli Lilly and Express Scripts are seeking to avoid potential bad press over high insulin prices.
Broadcom released better-than-expected 2016 fourth-quarter results, and its stock on Friday is giving a picture of where the rally could 'broaden to,' says Jim Cramer.
Biotechs were trading at high volumes Thursday morning on news that the Senate has passed the 21st Century Cures Act.
-- Mallinckrodt Earns Designation as a "Best Place to Work for LGBT Equality" on Human Rights Campaign Foundation's 15th Annual Scorecard on LGBT Workplace Equality --
Shares of Mallinckrodt were lower on Tuesday, despite posting better than expected fourth-quarter revenue and profits.
The pharmaceutical company saw shares fall more than 8% Tuesday.
The Nasdaq rose 0.7% to an all-time high of 5,403. The S&P 500 was up 0.3%, and the Dow Jones Industrial Average gained 0.2%.
The most recent short interest data has been released for the 11/15/2016 settlement date, and we here at Dividend Channel like to sift through this fresh data and order the underlying components of the S&P 500 by "days to cover." There are a number of ways to look at short data, for example the total number of shares short; but one metric that we find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares typically traded. The number of shares short is then compared to the average daily volume, in order to calculate the total number of trading days it would take to close out all of the open short positions if every share traded represented a short position being closed.
-- Investigational New Drug (IND) Application for use of H.P Acthar Gel in ALS Awarded Fast Track Designation by U.S. FDA --
-- Primary Data Show Altered Absorption of Oral Acetaminophen and Increased Variability when Co-Administered with IV Morphine --
-- Claims-based, retrospective data unveiled at the 2016 ACR/ARHP Annual Meeting--
Rosen Law Firm, a global investor rights law firm, announces it is investigating potential securities claims on behalf of shareholders of Mallinckrodt Public Limited Company (NYSE:MNK) resulting from allegations that...
The famed short-seller says the drug company could face a U.S. government crackdown.
Google announced it will set up a London headquarters. The move follows Apple's decision to shift 1,400 people to London's Battersea Power Station, the backdrop to Pink Floyd's album "Animals."
Citron Research issued a note Wednesday that accuses Mallinckrodt (MNK) CEO Mark Trudeau of committing fraud.
-- Data Show Small Improvements in Serum Creatinine (SCr) Associated with Increased Survival of Hepatorenal Syndrome Type 1 (HRS-1) Patients --
-- Mallinckrodt's Trial Designed to Measure Improvement in Disease Activity --
-- Mallinckrodt's Trial Designed to Measure Ability to Achieve Low Disease Activity --
These stocks are down some 20% over the last 30 months and look ripe for a rise.
TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,300 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: AYR, CRCM, TG Downgrades: ADPT, AMZN, ANGI, ARNC, BKD, BWXT, CAJ, CALX, CSGP, EMR, HZO, LXRX, MNK, MYGN, NTRA, PBI, TCO, TRI Initiations: PFGC Read on to get TheStreet Quant Ratings' detailed report: